Table 1.
Controls (n = 11) | CVID (n = 26) | P-value | |
---|---|---|---|
Demographics | |||
Gender (male/female, %) | 45/55 | 50/50 | 0·8 |
Age (years, median and 25th −75th percentiles) | 45 (38–65) | 49 (39–58) | 0·92 |
Clinical characteristics | |||
Bronchiectasis (%) | 69 | ||
Splenomegaly (%) | 58 | ||
Idiopathic thrombocytopenic purpura (%)* | 34 | ||
Granulomatous disease (%)** | 15 | ||
Therapy | |||
SCIG/IVIG (%)*** | 62/38 |
Cases include any history of idiopathic thrombocytopenic purpura.
Cases include granulomatous disease as confirmed by biopsy.
Some patients on IVIG received supplementary SCIG. IVIG: intravenous immunoglobulin therapy; SCIG: subcutaneous immunoglobulin therapy.